Protein Assays Market Research Report- Global Forecast till 2030

Protein Assays Market Research Report By Type (Copper-Ion-Based Assays, Test Strip-Based Assays, Dye-Binding Assays), Application (Diagnosis, Drug Discovery, Protein Purification), Product (reagents & kits, instruments and others), Technology (colorimetric-based protein assays, fluorescence-based protein assays, and absorbance-based protein assays), End User (hospitals & diagnostic centers, academic institutes, pharmaceutical & biotechnology companies and others) - Forecast till 2030

ID: MRFR/LS/3655-HCR | February 2023 | Region: Global | 120 Pages         

Protein Assays Market Speak to Analyst Request a Free Sample

Protein Assays Market

Protein Assays Market is expected to register a CAGR of 11.2 % and was valued at USD 2.96 Billion.

By Type Copper-Ion-Based Assays Test Strip-Based Assays Dye-Binding Assays
Application Diagnosis Drug Discovery Protein Purification
Product reagents & kits instruments and others
Technology colorimetric-based protein assays fluorescence-based protein assays and absorbance-based protein assays
End User hospitals & diagnostic centers academic institutes pharmaceutical & biotechnology companies and others
Key Players
Companies Profiled   GE Healthcare (U.S.)    Thermo Fisher Scientific (U.S.)    Bio-Rad Laboratories Inc. (U.S.)    Merck KGaA (Germany)    Cell Signaling Technology Inc. (U.S.)    Abcam plc (U.S.)    Lucigen Corporation (U.S.)    PerkinElmer Inc. (U.S.)    QIAGEN (Germany)
Market Driving Forces   Use of assay in disease diagnosis   Drug discovery and development
Request a Free Sample

Protein Assays Market Overview:

The protein assays market is expected to grow at a CAGR of approximately 11.20% during the forecast period 2022-2030. Protein assays are used in life science exploration to identify the presence of protein in an example. Different measures accessible in the market are contrasting based on awareness, guidelines, and systems. The full-scale factors, for example, test size, sum, meddling specialists and reproducibility, are likewise liable for its measurement. Protein tests depend, for the most part, on shading change, i.e., colourimetric measure and utilization of standard protein like immunoglobulin G (IgG) or ox-like serum egg whites (BSA). Protein measurement is the main advance before partition and investigation by electrophoresis, chromatography, or other immunochemical methods.

The utilization of protein measures for early determination of infections, for example, malignant growth and HIV, may fundamentally decrease the dreariness and mortality of the illness. These measures are financially savvy, easy and reproducible. Generally utilized protein measures are Bradford, Lowry, BCA, and UV spectroscopic protein examines. Consequently, utilization of measures in illness finding, drug disclosure and advancement support the biotechnology and drug industry to put resources into R&D, which powers the interest of the protein tests market.

A few new biomarker recognizable proof frameworks are sent off by the central participants, which awards different open doors for the protein measure market. For example, in June 2017, Gyros Protein Technologies AB sent off another rendition of its enemy of medication neutralizer (ADA) answer for the immunogenicity market. This arrangement empowers clients to run the tests productively, utilizing little volumes of patient examples and reagents and abbreviating run-times.

Covid-19 Analysis:

Since the COVID-19 infection explosion in December 2019, the infection has reached almost 90 nations worldwide, and the World Health Organization has pronounced it a general wellbeing crisis. The worldwide effects of the 2019 Covid illness (COVID-19) are now beginning to be felt and will impact the Protein Assays Market in 2020. Coronavirus can influence the worldwide economy in three primary ways: straightforwardly influencing creation and request, making interruptions in the store network and need, and its monetary effect on organizations and monetary business sectors. The COVID-19 episode has had impacts in numerous ways, like flight scratch-offs; travel boycotts and measured isolations; eateries shut; all confined inside occasions; over forty nations have proclaimed a highly sensitive situation; an enormous slump in the store network; financial exchange unpredictability; declining business certainty, developing public frenzy, and vulnerability about what's to come.

Chief Factors Existing in The Market:

  • Key Market Drivers:

Expanding drug and biotech R&D use and good government subsidizing situation for proteomics research are essential elements driving the worldwide Protein Assays Market. The Market is also expected to get popularity due to its different applications in different phases of the pre-clinical, clinical test, and later phases of medication advancement.

Besides, the protein examination market in Europe is anticipated to observe a quick trip driven by high interest in different private and government-financed innovative work programs inside the district and persistently expanding spending on drug and biotechnology area advancement.

The main considerations for the inspirational perspective are the broad improvement of the medical care framework and the developing accentuation of innovative work in the medical care area.

The good financial and segment factors like urbanization, developing populace, expendable salaries, and ascend in the way of life have decidedly expected in moving the development of the worldwide Protein Assays Market.

  • Market Challenges:

In Protein Assays Market analysis, some sure difficulties and restrictions will ruin the general market development. The variables like low innovative work (R&D) yields and high framework cost restrict market development. Likewise, severe administrative systems and the absence of prepared assets are assessed to languid development during the estimated time frame.

Further, issues connected with the advancement of protein examines for different infection types are the potential limitations hampering the general development of the worldwide protein tests market. The headways in advances, recognizable biomarker proof, and undiscovered capacity in developing business sectors offer positive learning experiences.

  • Market Opportunities:

Expanding subsidizing for Protein Assays Market forecast will be the main consideration driving the development of protein measures market development. In 2018, more than 18 million subsidies were given by Genome Canada and Genome BC for protein research. This subsidizing effectively interpreted exploration results into new methodologies for further developed treatment and conclusion of different infections. Furthermore, the rising requirement for quick determinations of a few sicknesses, including disease and Alzheimer's, will drive the interest for protein examines throughout the next few years.

  • Market Restraints:

Protein Assays Market value is a scientific strategy utilized to estimate protein's centralization in an answer. Protein tests are one of the most widely involved systems in life science review. Albeit a wide scope of protein tests is accessible in logical science, each sort of measure is interesting in its specific manner and has its benefits and restrictions. Consequently, a protein test should be chosen, considering its appropriateness for the application. 

The different protein tests in Protein Assays Market trends are accessible in the market vary in terms of strategy, explicitness, responsiveness, amount, and reproducibility. Determining protein focus is an important stage in protein purging, sub-atomic science, cell science, electrophoresis and other examination applications.

Cumulative Evaluation of The Market:

As indicated by distribution by Pharmaceuticals Research and Manufacturers of America (PhRMA), the associations spent around $58.8 billion on R&D in 2015, representing the biggest piece of all the biopharmaceutical R&D spending in the U.S. Notwithstanding the significant expense of multiplex examine equipment is restricting the development of protein measure market. 

Protein Assays Market Segmentation:

By Product

  • Reagents

  • Packs

  • Instruments and Accessories

The Protein Assays Market is bifurcated into Reagent, Kit, Instruments because of Product. The reagents portion holds the biggest piece of the pie and is assessed to witness the most elevated CAGR during the estimated time frame.

By Type

  • Color Binding Assays

  • Copper-Ion-Based Assays

  • Test Strip-Based Assays

  • Others

In light of Type, the Market is bifurcated into Dye Binding Assays, Test Strip Assays, Copper-Ion Assays, Others. The colour restricting measures fragment holds the biggest portion of the overall industry during the conjecture time frame. The elements that can be ascribed to are the rising use of colour restricting measures in illness analysis speeding up the interest for colour restricting examines portion.

By Technology

  • Absorbance-Based Protein Assays

  • Colorimetric-Based Protein Assays

  • Fluorescence-Based Protein Assays

In light of Technology, the Market is bifurcated into Absorbance-Based Protein Assays, Colorimetric-Based Protein Assays, Fluorescence-Based Protein Assays. The absorbance-based protein tests portion holds the biggest piece of the pie during the figure time frame. The elements that can be credited to the expanded awareness and exactness of absorbance-based protein tests inferable from the appearance of the new method are speeding up the interest for this portion.

By Application

  • Drug Discovery and Development

  • Sickness Diagnosis

  • Others

The market is bifurcated into Drug Discovery and Development, Disease Diagnosis, Others given Applications. The sickness finding fragment is assessed to witness the most elevated CAGR during the figure time frame. The variables ascribed to the rising reception of protein tests used to analyze malignant growth; resistant framework infections; and liver, kidney, and bone marrow illnesses.

By End-User

  • Drug and Biotechnology Companies

  • Emergency clinics

  • Clinical Laboratories

  • Scholarly Institutes

  • Others

Given End-User, the Protein Assays Market Share is bifurcated into Pharmaceutical and Biotechnology Companies, Hospitals, Clinical Laboratories, Academic Institutes, Others. The fragment of the drug and biotechnology organizations holds the biggest portion of the overall industry during the conjecture time frame. The elements that can be ascribed to the rising medication advancement in the existing science industry improve the interest of drug and biotechnology organizations.

Protein Assays Market by Geography

  • North America

  • Europe

  • the Asia Pacific

  • Rest of the world

Based on the provincial examination, the Protein Assays Market growth is grouped into North America, Europe, Asia Pacific, and the Rest of the world. Asia-Pacific holds the biggest piece of the pie. The rising R&D use in life science, expanding private-public associations for proteomics research, presence of arising economies like China, India, and Japan, and progressing tasks will help the market in the APAC locale.

Protein Assays Market Regional Analysis:

The Protein Assays Market comprises nations, specifically America, Europe, Asia Pacific, and the Middle East.

North America is projected to hold the biggest portion of the protein test market because of an unrivalled innovative work base, solid provincial financial matters, and more prominent accentuation on sickness anticipation and health by state run administrations.

The European protein measure market is supposed to observe quick development inferable from the high interest in different private and government-supported innovative work programs in the locale and expanded spending on drug and biotechnology industry improvement.

In the Asia Pacific, nations like China, Japan, and India are also ready to be promising business sectors for protein examination soon. Medical care consumption in Asia expanded because of an augmentation of state medical care programs and the rising wealth of the populace. 

India is expected to observe development in spending because of an administration goal to upgrade medical care administrations. Additionally, China and South Korea are endeavouring to foster their biotechnology area for determination reasons. China's endeavours to foster its biotech area have shown great outcomes in areas like antibodies and natural items, and the equivalent can be anticipated in the protein measures industry. 

Nonetheless, low innovative work (R&D) yields, high foundation cost, severe administrative structure, and absence of prepared assets are a portion of the restrictions of the protein examine the market.

The Middle East locale is supposed to develop quicker because of the elements, for example, the broad advancement of the medical care framework and developing accentuation on innovative work in the medical care area.

Protein Assays Market Competitive Landscape:

Many new organizations have bounced into the Protein Assays Market to make the most out of the potential open doors. Organizations are carrying out the methodologies of consolidations and acquisitions with different players. For example, in June 2015, Thermo Fisher Scientific Inc. presented the Orbitrap Fusion Lumos Tribrid mass spectrometer and refreshed the gadget in 2017.

Some of key the players in the protein tests market are GE Healthcare (U.S.), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology Inc. (U.S.), Abcam plc (U.S.), Lucigen Corporation (U.S.), PerkinElmer Inc. (U.S.), QIAGEN (Germany), Lonza Group Ltd. (Switerzland), Bio-Techne (U.S.), BioVision Inc. (U.S.), Illumina Inc. (U.S.), New England Biolabs (U.S.), Takara Bio Inc. (Japan), Promega Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switerzland), and others.

Protein Assays Market Developments:

In January 2019, the FDA grew new rules for the immunogenicity testing of helpful protein items. It gives suggestions to every office to create and approve tests for the location of medication antibodies.

In August 2018, Becton, Dickinson, and Company delivered the most recent measure for protein examination. The BD ‚ĄĘ AbSeq measure will help examine proteins at the single-cell level utilizing raised throughput sequencing.

On February 27, 2019: PhD, an associate teacher of cell and tissue science in the School of Dentistry, Stephen Floor, used an imaginative system called long-perused sequencing to examine a whole strand of RNA regardless of being separated into little pieces. With the innovation approach, the way of behaving of RNA and its result can be examined in various sums and sorts of proteins.

Report Overview:

This report on Market expects to learn about the worldwide protein measures market. Subtleties on territorial business sectors for these fragments are likewise introduced. Furthermore, driving players in the Protein Assays Market outlook are profiled to concentrate on their item contributions and comprehend the techniques they attempted to be serious in this market.

Key Segments:

Protein Assays Market ‚Äď

  • By Product: Reagents Kits Instruments

  • By Type: Dye-Binding Copper-Ion Based Test Strip

  • By Technology: Absorbance Colorimetric Fluorescence

  • By Application: Drug Discovery Diagnosis

  • By End User: Academic and Research Institutes Pharmaceutical and Biotechnology Companies Hospitals Clinical Laboratories

  • By Region: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

Report Scope:

Report Attribute/Metric Details
  Market Size   2030: Significant Value
  CAGR   11.20%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Application, Product, Technology and End-users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   GE Healthcare (U.S.), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology Inc. (U.S.), Abcam plc (U.S.), Lucigen Corporation (U.S.), PerkinElmer Inc. (U.S.), QIAGEN (Germany), Lonza Group Ltd. (Switerzland), Bio-Techne (U.S.), BioVision Inc. (U.S.), Illumina Inc. (U.S.), New England Biolabs (U.S.), Takara Bio Inc. (Japan), Promega Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switerzland), and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Use of assay in disease diagnosis
  • Drug discovery and development

  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Protein Assays Market is expected to expand at 11.20% CAGR from 2022-2030.

    Early detection of diseases at a preventive stage is the primary driver of the Protein Assays Market.

    High costs of multiplex assay hardware is the major factor expected to impede the Protein Assays Market growth.

    North America is expected to dominate in the protein assays market till 2030.

    F. Hoffmann-La Roche Ltd, Abcam plc, PerkinElmer Inc., QIAGEN, GE Healthcare, BioVision Inc., Cell Signaling Technology Inc., Illumina Inc., Thermo Fisher Scientific, Bio-Rad Laboratories Inc., Lucigen Corporation, New England Biolabs, Promega Corporation, Takara Bio Inc., Merck KGaA, Lonza Group Ltd., and Bio-Techne are prominent players of the Protein Assays Market.